Vasopressor Induced Acute Limb Ischemia and the Role of Local Vasodilators: Case Report and Review of the Literature
Authors:
- 19 November 2026
- journal article
- review article
- Published by SAGE Publications in Journal of Pharmacy Practice
Abstract
Vasopressor induced acute limb ischemia (VIALI) is a potentially devastating disorder that presents with initial findings of peripheral ischemia and may rapidly progress to gangrene, resulting in a 30 day amputation rate of 10 to 30%. Early recognition in patients at heightened risk is key to facilitate timely intervention before development of irreversible necrosis. This case is a 59 year-old female with septic and cardiogenic shock who developed VIALI after 4 days of exposure to vasopressors. The patient presented with dry gangrene of right index finger and right toes, attributable to administration of combination vasopressor agents which were successfully discontinued. While early interventions were hampered by the sudden onset of tissue necrosis and minimal accompanying symptoms, a review of the literature involving local vasodilators, with evidence-based treatment for nonpharmacologic and pharmacologic sources of limb ischemia, is provided. Topical nitroglycerin ointment, most often 1 to 2%, applied 3 to 4 times daily, demonstrated evidence of resolution of tissue ischemia and symptoms, tolerability, and convenience. Phentolamine and botulinum toxin also proved effective in resolving digital ischemia, but their use may be hindered by availability, administration challenges, or delayed onset. The case illustrates the sudden occurrence, often advanced presentation of VIALI, emphasizing the importance of early detection and intervention, and provides evidence for the role of local vasodilators in potentially altering disease outcomes without added systemic adverse effects.Funding Information
- No funding
This publication has 26 references indexed in Scilit:
- Vasopressor-Induced Digital Ischemia: Management and Treatment ConsiderationsThe Journal of Hand Surgery, 2026
- Beyond Raynaud's: Atypical Peripheral Vascular Manifestations in a Case of CREST SyndromeClinical Case Reports, 2026
- Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic SclerosisJAMA Dermatology, 2026
- 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery DiseaseJACC, 2024
- Management of vasopressor induced ischemiaJournal of Orthopaedics, 2020
- Adrenaline Auto-injector injuries to digits; a systematic review and recommendations for emergency managementThe Surgeon, 2020
- Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb IschaemiaEuropean Journal of Vascular and Endovascular Surgery, 2020
- Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trialsIntensive Care Medicine, 2019
- A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenonJournal of the American Academy of Dermatology, 2018
- Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive ShockJAMA, 2018